When the Sleep Aid Is Part of the Problem

The dementia headline is the weakest part of the case against these drugs. The rest of the case is much stronger, and almost nobody makes it.

What is actually in an over-the-counter sleep aid?

Almost every nighttime sleep product relies on one of two first-generation antihistamines: diphenhydramine or doxylamine succinate.

Diphenhydramine is the “PM” in Tylenol PM and Advil PM, and the active ingredient in ZzzQuil and Benadryl. Doxylamine succinate is the active ingredient in Unisom SleepTabs. Both were designed for allergies; the drowsiness they cause was a side effect that got repackaged as a selling point.

Both are also strongly anticholinergic — meaning they block acetylcholine, a brain chemical that is central to memory and learning. That single property is the heart of the concern.

Do these sleep aids really increase dementia risk?

Less clearly than this page said when it was first published. The dementia case against sleep aids specifically is the weakest part of the argument against them — and the rest of the argument is much stronger.

Corrected August 2026. An earlier version of this page applied the well-known 54% figure to sleep aids and said a 2019 study "found a similar pattern." Neither statement holds up, and the correction matters enough to lead with.

The 54% is real. Gray and colleagues, in JAMA Internal Medicine in 2015, followed 3,434 adults aged 65 and over and found the heaviest users of strong anticholinergic drugs had an adjusted hazard ratio of 1.54 for dementia. But that figure describes anticholinergics as a group. In that cohort, antidepressants accounted for 63.1% of the total anticholinergic exposure by dose; antihistamines — the sleep-aid ingredients — accounted for 17.2%. No antihistamine-specific hazard ratio was published. In fairness to that paper, its authors did report that risk looked similar when they split antidepressants from all other classes, so it is not silent on the question.

What settled it came afterward, and it points the other way. Coupland and colleagues (JAMA Internal Medicine, 2019) studied 58,769 dementia cases against 225,574 controls and wrote that there were "no significant increases in risk associated with antihistamines" — while finding clear associations for antidepressants, bladder antimuscarinics, antiparkinson and antiepileptic drugs in the very same analysis. Richardson and colleagues (BMJ, 2018), in a separate UK database of 40,770 cases and 283,933 controls, got the same result: antihistamines null at every time window, other classes clearly associated.

So the accurate statement is narrower than either the scare version or the all-clear: there is no good study of over-the-counter sleep aids and dementia risk, and in the prescription data that does exist, antihistamines do not show the signal other anticholinergic classes do.

None of which makes these drugs a good idea after 65. The American Geriatrics Society Beers Criteria still say to avoid first-generation antihistamines in older adults — a strong recommendation — and the reasons are on this page: falls, next-day impairment, delirium, tolerance. A 2018 meta-analysis in Osteoporosis International found roughly double the odds of an injurious fall or fracture (OR 2.03). That is the case worth making, and it does not need the dementia headline to stand up.

The full evidence review is here — what each study actually measured, and why the number keeps getting misquoted.

Why do these sleep aids stop working — and what are the day-to-day risks?

Used nightly, they build tolerance within days to weeks, and their anticholinergic effects cause grogginess, confusion, and falls.

The dose that knocked you out last week does a little less this week, so it is easy to take more — which quietly compounds your exposure. Meanwhile, the anticholinergic effects show up in daytime life: next-day grogginess, dry mouth, constipation, blurred vision, and — most important for a caregiver — confusion and unsteadiness that raise the risk of a fall.

You cannot afford to be foggy at 7am when someone depends on you for their medications, meals, and safety. The thing helping you sleep may be quietly taxing the exact faculties caregiving demands.

What should a caregiver do instead?

If you use these occasionally, this is information, not an emergency. If you take one most nights, ask your doctor or pharmacist about gentler alternatives.

Do not stop a medication abruptly on your own; ask what makes sense for your situation. It helps to walk in knowing there are options that do not carry the anticholinergic load:

• Low-dose melatonin (0.5–1 mg) — far less than the 5–10 mg in many products.
• L-theanine and magnesium glycinate — mild and non-habit-forming.
• Valerian — a traditional sleep herb with modest evidence.
• CBT-I (cognitive behavioral therapy for insomnia) — the most effective long-term approach, and drug-free, now widely available through apps and telehealth.

None of these will fix the 3am wake-up to check a locked door, or the worry that has taken up residence in your chest. Caregiver sleep is hard for reasons no pill fully solves. But the goal is to protect your rest without borrowing against your own brain to get it.